Abstract
Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a condition in which there is a defect in adrenal steroidogenesis leading to defective cortisol production, salt wasting, and varying degrees of hyperandrogenism. This lifelong endocrine condition requires multiple medications, frequent laboratory evaluation, and close monitoring to prevent adverse long-term outcomes. The management of CAH can be challenging, especially during the transition from pediatric to adult care. During adolescence, specific treatment and educational topics for patients and families must be addressed by the medical team to help prepare for managing CAH in adulthood. The aim of this chapter is to discuss management goals in the adolescent period, psychosocial and educational issues specific to CAH that should be addressed with patients and families, and appropriate transition practices from pediatric to adult care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21(3):245–91.
Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(9):4133–60.
Turcu AF, Auchus RJ. The next 150 years of congenital adrenal hyperplasia. J Steroid Biochem Mol Biol. 2015;153:63–71.
Levine LS, Dupont B, Lorenzen F, Pang S, Pollack M, Oberfield SE, et al. Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1981;53(6):1193–8.
Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibanez L, et al. 21-hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol. 2000;183(6):1468–74.
Pasterski V, Hindmarsh P, Geffner M, Brook C, Brain C, Hines M. Increased aggression and activity level in 3- to 11-year-old girls with congenital adrenal hyperplasia (CAH). Horm Behav. 2007;52(3):368–74.
Pasterski V, Geffner ME, Brain C, Hindmarsh P, Brook C, Hines M. Prenatal hormones and childhood sex segregation: playmate and play style preferences in girls with congenital adrenal hyperplasia. Horm Behav. 2011;59(4):549–55.
Dittmann RW, Kappes ME, Kappes MH. Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia. Psychoneuroendocrinology. 1992;17(2–3):153–70.
Berenbaum SA, Korman Bryk K, Duck SC, Resnick SM. Psychological adjustment in children and adults with congenital adrenal hyperplasia. J Pediatr. 2004;144(6):741–6.
Slijper FME, van der Kamp HJ, Brandenburg H, Keizer-Schrama SMPFM, Drop SLS, Molenaar JC. Evaluation of psychosexual development of young women with congenital adrenal hyperplasia: a pilot study. J Sex Educ Ther. 1992;18(3):200–7.
Zucker KJ, Bradley SJ, Oliver G, Blake J, Fleming S, Hood J. Psychosexual development of women with congenital adrenal hyperplasia. Horm Behav. 1996;30(4):300–18.
Strandqvist A, Falhammar H, Lichtenstein P, Hirschberg AL, Wedell A, Norrby C, et al. Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden. J Clin Endocrinol Metab. 2014;99(4):1425–32.
Sanches SA, Wiegers TA, Otten BJ, Claahsen-van der Grinten HL. Physical, social and societal functioning of children with congenital adrenal hyperplasia (CAH) and their parents, in a Dutch population. Int J Pediatr Endocrinol. 2012;2012(1):2.
Falhammar H, Thoren M. Clinical outcomes in the management of congenital adrenal hyperplasia. Endocrine. 2012;41(3):355–73.
Charmandari E, Hindmarsh PC, Johnston A, Brook CG. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty. J Clin Endocrinol Metab. 2001;86(6):2701–8.
Auchus RJ, Arlt W. Approach to the patient: the adult with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2013;98(7):2645–55.
Hagenfeldt KB. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency – the adult woman. Growth Hormon IGF Res. 2004;14(Suppl A):S67–71.
White PC, Speiser PW. Long-term consequences of childhood-onset congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab. 2002;16(2):273–88.
Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL, et al. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. 1994;79(5):1328–33.
Mueller SC, Ng P, Sinaii N, Leschek EW, Green-Golan L, VanRyzin C, et al. Psychiatric characterization of children with genetic causes of hyperandrogenism. Eur J Endocrinol. 2010;163(5):801–10.
Claahsen-van der Grinten HL, Otten BJ, Stikkelbroeck MM, Sweep FC, Hermus AR. Testicular adrenal rest tumours in congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab. 2009;23(2):209–20.
Aycan Z, Bas VN, Cetinkaya S, Yilmaz Agladioglu S, Tiryaki T. Prevalence and long-term follow-up outcomes of testicular adrenal rest tumours in children and adolescent males with congenital adrenal hyperplasia. Clin Endocrinol. 2013;78(5):667–72.
Claahsen-van der Grinten HL, Otten BJ, Takahashi S, Meuleman EJ, Hulsbergen-van de Kaa C, Sweep FC, et al. Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients. J Clin Endocrinol Metab. 2007;92(2):612–5.
Kruse B, Riepe FG, Krone N, Bosinski HA, Kloehn S, Partsch CJ, et al. Congenital adrenal hyperplasia – how to improve the transition from adolescence to adult life. Exp Clin Endocrinol Diabetes. 2004;112(7):343–55.
Gleeson H, Davis J, Jones J, O'Shea E, Clayton PE. The challenge of delivering endocrine care and successful transition to adult services in adolescents with congenital adrenal hyperplasia: experience in a single centre over 18 years. Clin Endocrinol. 2013;78(1):23–8.
Bachelot A, Vialon M, Baptiste A, Tejedor I, Elie C, Polak M, et al. Impact of transition on quality of life in patients with congenital adrenal hyperplasia diagnosed during childhood. Endocr Connect. 2017.
CARES Foundation: Congenital Adrenal Hyperplasia Research Education & Support 2018 [Internet]. [cited August 2018]. Available from: www.caresfoundation.org.
Hormone Health Network, The Endocrine Society 2018 [Internet]. [updated September 2017; cited August 2018]. Available from: https://www.hormone.org/diseases-and-conditions/adrenal/congenital-adrenal-hyperplasia.
Congenital adrenal hyperplasia: a guide for families. Pediatric Endocrine Society 2017 [Internet].[cited August 2018]. Available from: https://www.pedsendo.org/assets/patients_families/EdMat/first_batch/Congenital%20adrenal%20hyperplasia.pdf.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
McCann-Crosby, B. (2019). Transition Considerations for Congenital Adrenal Hyperplasia. In: Lyons, S., Hilliard, M. (eds) Transitioning from Pediatric to Adult Care in Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-030-05045-0_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-05045-0_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-05044-3
Online ISBN: 978-3-030-05045-0
eBook Packages: MedicineMedicine (R0)